De La Villa Polo, Pedro,Bosch Tubert, Fatima,De Pablo Davila, Maria Flora,Boya Tremoleda, Patricia,De La Rosa Cano, Enrique J.,Barhoum Tannous, Rima,Corrochano Sanchez, Silvia
申请号：
AU2007253212
公开号：
AU2007253212B2
申请日:
2007.05.21
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The present invention relates to the use of a compound that induces the activity of proinsulin, preferably human proinuslin, for the preparation of a medicinal product or pharmaceutical composition for the prevention and treatment of neurodegenerative conditions, disorders or diseases involving programmed cell death, preferably neurodegenerative pathologies of the central and peripheral nervous systems, and, more preferably, of the heredodegenerative diseases known as retinosis pigmentosa. The activator compound may consist of a chemical molecule, a peptide, a protein or a nucleotide sequence.
